257 related articles for article (PubMed ID: 18927532)
1. Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
Bertelli M; Luongo R; Barcella L; Cavalli P
Panminerva Med; 2008 Sep; 50(3):260-1. PubMed ID: 18927532
[No Abstract] [Full Text] [Related]
2. Secondary prevention of ischaemic stroke and TIA.
Diener HC
Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
[No Abstract] [Full Text] [Related]
3. Antiplatelet drugs for ischemic stroke prevention.
Leys D; Balucani C; Cordonnier C
Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
[TBL] [Abstract][Full Text] [Related]
4. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
Lutsep HL
J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
[TBL] [Abstract][Full Text] [Related]
5. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
Cavendish JJ; Cramer SC; Graham GD
Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
[TBL] [Abstract][Full Text] [Related]
6. Use of antiplatelet agents for prevention of ischemic stroke.
Callison RC; Adams HP
Neurol Clin; 2008 Nov; 26(4):1047-77, ix. PubMed ID: 19026902
[TBL] [Abstract][Full Text] [Related]
7. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
Griffin G
Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
[No Abstract] [Full Text] [Related]
8. [Antiplatelet treatment for secondary prevention of ischemic stroke or transient ischemic attack].
Barinagarrementeria F; Arauz A; Ruiz-Sandoval JL; Cantú C; Leyva A; Murillo L; Villarreal J; Vargas RD; Alegría MA; Merino JG; Romano J;
Rev Invest Clin; 2010; 62(2):135-40. PubMed ID: 20597393
[No Abstract] [Full Text] [Related]
9. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
10. Premorbid antiplatelet use and ischemic stroke outcomes.
Li HF; Pan XD
Neurology; 2006 Nov; 67(9):1723; author reply 1723. PubMed ID: 17101925
[No Abstract] [Full Text] [Related]
11. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
[TBL] [Abstract][Full Text] [Related]
12. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
Weber R; Weimar C; Diener HC
Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
[TBL] [Abstract][Full Text] [Related]
13. Functional outcome and prevalence of recurrent ischemic events in patients with acute ischemic stroke due to aortic plaques.
Baumann CR; Baumgartner RW; von Büdingen HC; Rousson V; Siegel AM; Georgiadis D
Cerebrovasc Dis; 2007; 24(1):127-9. PubMed ID: 17565198
[No Abstract] [Full Text] [Related]
14. [Secondary prevention of ischemic cerebrovascular accidents].
Jerbi Z; Borsali-Falfoul N; Touir F; Hachicha Y; Chergui A
Tunis Med; 2002; 80(8 Suppl):8-13. PubMed ID: 12698546
[No Abstract] [Full Text] [Related]
15. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
Park MK; Smith PC; Wanserski G; Neher JO
Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970
[No Abstract] [Full Text] [Related]
16. Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
Kirshner HS
J Neurol Sci; 2009 Apr; 279(1-2):1-8. PubMed ID: 19185319
[TBL] [Abstract][Full Text] [Related]
17. [Secondary prevention of ischemic cerebral accidents].
Ducrocq X
Soins; 2001 Oct; (659):48-50. PubMed ID: 12012687
[No Abstract] [Full Text] [Related]
18. Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?
Talelli P; Greenwood RJ
Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):387-405. PubMed ID: 19124436
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease?
Beckman JA
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S12-6. PubMed ID: 19530155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
